The US Food and Drug Administration's Approval of Adjuvant Sunitinib for Renal Cell Cancer: A Case of Regulatory Capture?
作者信息
Gyawali Bishal, Goldstein Daniel A
机构信息
Institute of Cancer Policy, King's College, London, England.
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston.
出版信息
JAMA Oncol. 2018 May 1;4(5):623-624. doi: 10.1001/jamaoncol.2017.5697.
PMID:29522146
Abstract
摘要
Zotero 插件